Enzyme inhibitors
US11613527B2 · kind B2 · utility
0Cited by
16References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2021 |
| Grant date | Mar 28, 2023 |
| Priority date | — |
| Expiry date | Nov 6, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.